{"schema_version":"secwatch.filing_event.v1","accession":"0001653477-24-000096","form_type":"8-K","ticker":"NGVT","cik":"0001653477","company_name":"Ingevity Corp","filed_at":"2024-10-29T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.118578+00:00","generated_at":"2026-05-30T09:17:58.571921+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"negative","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Ingevity Q3 net loss $107.2M; sales down 16% YoY; affirms FY adjusted EBITDA guidance","bullets":["Net sales $376.9M, down 16% YoY, primarily due to Performance Chemicals repositioning.","Net loss $107.2M ($2.95 diluted EPS) includes $86.9M restructuring charges and $100M contract termination fees.","Adjusted EPS $1.10; adjusted EBITDA $106.4M (28.2% margin).","Full-year guidance: sales $1.40-$1.50B, adjusted EBITDA $350-$360M.","Operating cash flow $46.5M, free cash flow $28.5M."],"urls":{"canonical":"https://secwatch.observer/filing/0001653477-24-000096","json":"https://secwatch.observer/filing/0001653477-24-000096.json","markdown":"https://secwatch.observer/filing/0001653477-24-000096.md","text":"https://secwatch.observer/filing/0001653477-24-000096.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1653477/000165347724000096/0001653477-24-000096-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1653477/000165347724000096/ngvt-20241029.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:17:58.571921+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}